Sort
64,565 grants matching “drug discovery”
Computational Approaches for RNA StructureFunction Determination
$532,222Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Chromatin Biology of the African Trypanosome
$532,204Erik Debler · Thomas Jefferson University · R01 · FY2023 · AI
Human Genetics and Molecular Mechanisms of Vein of Galen Aneurysmal Malformation
$532,195Kristopher Kahle · Massachusetts General Hospital · R01 · FY2024 · NS
Simultaneous Stimulation and Recording in Scalable Microelectrode Arrays
$532,193James Ross · Axion Biosystems, Llc · R44 · FY2010 · NS
Cell Biology of Metabolic Disorders
$532,175William Gahl · National Human Genome Research Institute · ZIA · FY2013 · HG
Drug Action, Metabolism and Kinetics Training Grant
$532,173William M Atkins · University Of Washington · T32 · FY2023 · GM
Measure the metabolic and genetic factors that determine M. Tuberculosis
$532,144David Branch Moody · Brigham And Women'S Hospital · U19 · FY2017 · AI
Magnetic Resonance-guided Focused Ultrasound Ablation of the Anterior Thalamus as a Novel Treatment Paradigm for Anxiety
$532,134Kinh Luan Phan · Ohio State University · U01 · FY2022 · MH
Assembly and characterization of human cortico-striatal neural networks
$532,099Oleksandr Shcheglovitov · University Of Utah · R01 · FY2023 · NS
Research and Deployment of a quantum mechanical NMR tool for fragment based drug
$532,078Lance M Westerhoff · Quantumbio, Inc. · R44 · FY2013 · GM
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
$532,030Lynette C Daws · University Of Texas Hlth Science Center · R01 · FY2015 · MH
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
$532,030Lynette C Daws · University Of Texas Hlth Science Center · R01 · FY2016 · MH
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
$532,030Lynette C Daws · University Of Texas Hlth Science Center · R01 · FY2014 · MH
GOALI: Taming Ambident Reactivity in the Alkylations of Pharmaceutically Relevant N,O-Heterocycles via Catalysis
$532,000Douglas E Frantz · Washington University · · FY2025 · MPS
CAREER: Mechanobiology of Mesenchymal-Epithelial Transition
$532,000Esther W Gomez · Pennsylvania State Univ University Park · · FY2018 · ENG
Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of Fibrosis
$531,955Chelsea M Magin · University Of Colorado Denver · R01 · FY2023 · HL
Institute for Translational Health Science (TL1)
$531,926Mary L. Disis · University Of Washington · TL1 · FY2008 · RR
A microfluidic chemotaxis device for high content screening
$531,899Ivar Meyvantsson · Bellbrook Labs, Llc · R44 · FY2009 · HL
A synergy-based therapy against C. difficile
$531,817Kim Lewis · Northeastern University · R01 · FY2012 · AI
Selectively Targeting Oncogenic NRAS in Cancer
$531,791Kevin M Shannon · University Of California, San Francisco · R01 · FY2021 · CA
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY
$531,704Deok-Ho Kim · Johns Hopkins University · R01 · FY2021 · HL
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY
$531,704Deok-Ho Kim · Johns Hopkins University · R01 · FY2022 · HL
Inhibitors of protein-protein interactions
$531,607Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Discovering targets for neuroblastoma differentiation therapy from the human druggable genome
$531,550Liqin Du · Texas State University · R15 · FY2025 · CA
Designing Drugs That Supress Chronic Brain InFlammation
$531,512Anton D Solovyov · Inflame Therapeutics, Inc. · R44 · FY2009 · NS